Literature DB >> 27810953

Weight gain in mice on a high caloric diet and chronically treated with omeprazole depends on sex and genetic background.

Milena Saqui-Salces1, Amy C Tsao2, Merritt G Gillilland2, Juanita L Merchant2,3.   

Abstract

The impact of omeprazole (OM), a widely used over-the-counter proton pump inhibitor, on weight gain has not been extensively explored. We examined what factors, e.g., diet composition, microbiota, genetic strain, and sex, might affect weight gain in mice fed a high caloric diet while on OM. Inbred C57BL/6J strain, a 50:50 hybrid (B6SJLF1/J) strain, and mice on a highly mixed genetic background were fed four diets: standard chow (STD, 6% fat), STD with 200 ppm OM (STD + O), a high-energy chow (HiE, 11% fat), and HiE chow with OM (HiE + O) for 17 wk. Metabolic analysis, body composition, and fecal microbiota composition were analyzed in C57BL/6J mice. Oral glucose tolerance tests were performed using mice on the mixed background. After 8 wk, female and male C57BL/6J mice on the HiE diets ate less, whereas males on the HiE diets compared with the STD diets gained weight. All diet treatments reduced energy expenditure in females but in males only those on the HiE + O diet. Gut microbiota composition differed in the C57BL/6J females but not the males. Hybrid B6SJLF1/J mice showed similar weight gain on all test diets. In contrast, mixed strain male mice fed a HiE + O diet gained ∼40% more weight than females on the same diet. In addition to increased weight gain, mixed genetic mice on the HiE + O diet cleared glucose normally but secreted more insulin. We concluded that sex and genetic background define weight gain and metabolic responses of mice on high caloric diets and OM.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  acid suppression; energy expenditure; gastrin; metabolism; microbiota

Mesh:

Substances:

Year:  2016        PMID: 27810953      PMCID: PMC5283905          DOI: 10.1152/ajpgi.00211.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  43 in total

1.  Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole.

Authors:  G R Betton; C S Dormer; T Wells; P Pert; C A Price; P Buckley
Journal:  Toxicol Pathol       Date:  1988       Impact factor: 1.902

2.  Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period.

Authors:  P F Haastrup; M S Paulsen; R D Christensen; J Søndergaard; J M Hansen; D E Jarbøl
Journal:  Aliment Pharmacol Ther       Date:  2016-05-03       Impact factor: 8.171

3.  Mouse strain modulates the role of the ciliated cell in acute tracheobronchial airway injury-distal airways.

Authors:  Gregory W Lawson; Laura S Van Winkle; Elina Toskala; Robert M Senior; William C Parks; Charles G Plopper
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.

Authors:  Sinju Sundaresan; Anthony J Kang; Michael M Hayes; Eun-Young K Choi; Juanita L Merchant
Journal:  Gut       Date:  2016-02-09       Impact factor: 23.059

5.  Omeprazole-induced slowing of gastrointestinal transit in mice can be countered with tegaserod.

Authors:  Alan Cowan; David L Earnest; Gregory Ligozio; Mikhail A Rojavin
Journal:  Eur J Pharmacol       Date:  2005-07-04       Impact factor: 4.432

6.  Effect of 7 years' daily oral administration of omeprazole to beagle dogs.

Authors:  C Säfholm; N Havu; H Forssell; G Sundell; H Mattsson
Journal:  Digestion       Date:  1994       Impact factor: 3.216

7.  Strain-dependent brain defects in mouse models of primary ciliary dyskinesia with mutations in Pcdp1 and Spef2.

Authors:  R Finn; C C Evans; L Lee
Journal:  Neuroscience       Date:  2014-07-27       Impact factor: 3.590

8.  Changes in gene expression foreshadow diet-induced obesity in genetically identical mice.

Authors:  Robert A Koza; Larissa Nikonova; Jessica Hogan; Jong-Seop Rim; Tamra Mendoza; Christopher Faulk; Jihad Skaf; Leslie P Kozak
Journal:  PLoS Genet       Date:  2006-05-26       Impact factor: 5.917

9.  Proton pump inhibitors alter the composition of the gut microbiota.

Authors:  Matthew A Jackson; Julia K Goodrich; Maria-Emanuela Maxan; Daniel E Freedberg; Julian A Abrams; Angela C Poole; Jessica L Sutter; Daphne Welter; Ruth E Ley; Jordana T Bell; Tim D Spector; Claire J Steves
Journal:  Gut       Date:  2015-12-30       Impact factor: 23.059

10.  Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.

Authors:  Vera H I Fengler; Tanja Macheiner; Sonja M Kessler; Beate Czepukojc; Katja Gemperlein; Rolf Müller; Alexandra K Kiemer; Christoph Magnes; Johannes Haybaeck; Carolin Lackner; Karine Sargsyan
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

View more
  1 in total

1.  Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer.

Authors:  Fei Liu; Jianxin Fu; Kirk Bergstrom; Xindi Shan; J Michael McDaniel; Samuel McGee; Xia Bai; Weichang Chen; Lijun Xia
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.